Ubs Group Ag Biotechnology

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
XBIT X Biotech Inc.	$90.4M	$15,000 0.0% of portfolio	5,051	Q2 2025 Reduced 86.82%
ACIU Ac Immune Sa	$179M	$15,000 0.0% of portfolio	7,467	Q2 2025 Reduced 55.26%
ADAP Adaptimmune Therapeutics PLC	$13.1M	$15,000 0.0% of portfolio	62,958	Q2 2025 Reduced 93.78%
IPSC Century Therapeutics, Inc.	$30.6M	$15,000 0.0% of portfolio	28,026	Q2 2025 Added 43.46%
GNFT Genfit S.A.	$189M	$15,000 0.0% of portfolio	4,081	Q2 2025 Added 30.89%
PEPG Pep Gen Inc.	$28.8M	$14,000 0.0% of portfolio	13,362	Q2 2025 Reduced 61.01%
AADI Aadi Bioscience, Inc.	$35.9M	$14,000 0.0% of portfolio	8,673	Q2 2025 Reduced 75.62%
ACET Adicet Bio, Inc.	$25.6M	$11,000 0.0% of portfolio	18,508	Q2 2025 Reduced 71.1%
BCAB Bio Atla, Inc.	$13.4M	$11,000 0.0% of portfolio	29,575	Q2 2025 Reduced 38.85%
NAUT Nautilus Biotechnology, Inc.	$88.5M	$11,000 0.0% of portfolio	16,320	Q2 2025 Reduced 25.03%
IPHA Innate Pharma Sa	$165M	$10,000 0.0% of portfolio	5,957	Q2 2025 Reduced 33.82%
OVID Ovid Therapeutics Inc.	$38.7M	$7,000 0.0% of portfolio	21,669	Q2 2025 Reduced 19.62%
IPA Immuno Precise Antibodies Ltd.	$50.2M	$6,000 0.0% of portfolio	6,266	Q2 2025 Reduced 17.11%
IFRX Infla Rx N.V.	$36.7M	$6,000 0.0% of portfolio	8,095	Q2 2025 New
TLSA Tiziana Life Sciences LTD	$228M	$6,000 0.0% of portfolio	4,289	Q2 2025 Reduced 12.45%
IGMS Igm Biosciences, Inc.	$37.7M	$5,000 0.0% of portfolio	4,627	Q2 2025 Reduced 88.74%
LEXX Lexaria Bioscience Corp.	$4.94M	$5,000 0.0% of portfolio	6,074	Q2 2025 New
NXTC Next Cure, Inc.	$134M	$5,000 0.0% of portfolio	12,299	Q2 2025 Added 44.07%
HOWL Werewolf Therapeutics, Inc.	$35.4M	$3,000 0.0% of portfolio	3,438	Q2 2025 Reduced 80.56%
CGTX Cognition Therapeutics Inc	$25M	$3,000 0.0% of portfolio	11,255	Q2 2025 Added 1,125,400.0%
MAIA Maia Biotechnology, Inc.	$18.2M	$3,000 0.0% of portfolio	2,120	Q2 2025 Added 606.67%
NRSN Neuro Sense Therapeutics Ltd.	$14.7M	$3,000 0.0% of portfolio	1,611	Q2 2025 Reduced 29.19%
CRTX Cortexyme, Inc.	$70.5M	$3,000 0.0% of portfolio	2,846	Q2 2025 Added 303.12%
XTLB Xtl Biopharmaceuticals LTD	$7.52M	$1,000 0.0% of portfolio	1,336	Q2 2025 New
NERV Minerva Neurosciences, Inc.	$9.4M	$1,000 0.0% of portfolio	875	Q2 2025 Reduced 46.02%
ANEB Anebulo Pharmaceuticals, Inc.	$61M	$0 0.0% of portfolio	92	Q2 2025 Added 9,100.0%
ARMP Armata Pharmaceuticals, Inc.	$88.9M	$0 0.0% of portfolio	1	Q2 2025 Reduced 99.94%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	866,935	Q2 2025 Added 46.64%
BRTX Bio Restorative Therapies, Inc.	$5.37M	$0 0.0% of portfolio	3	Q2 2025 Reduced 99.96%
CMMB Chemomab Therapeutics Ltd.	$10.5M	$0 0.0% of portfolio	397	Q2 2025 Reduced 55.04%
CNTB Connect Biopharma Holdings LTD	$125M	$0 0.0% of portfolio	42	Q2 2025 Reduced 99.52%
CNTX Context Therapeutics Inc.	$10.9M	$0 0.0% of portfolio	370	Q2 2025 Reduced 14.35%
DRMAW Dermata Therapeutics Inc Wt Ex	$0	$0 0.0% of portfolio	1,880	Q2 2025 Reduced 28.16%
IMRN Immuron Limited	$11.8M	$0 0.0% of portfolio	-	Q2 2025 New
NRXPW Nrx Pharmaceuticals Inc Wt Exp	$0	$0 0.0% of portfolio	1,500	Q2 2025 Added 45.35%
NTRB Nutri Band Inc.	$53.1M	$0 0.0% of portfolio	1	Q2 2025 Reduced 99.98%
PASG Passage Bio, Inc.	$306M	$0 0.0% of portfolio	3	Q2 2025 Reduced 99.98%
PRTC Pure Tech Health PLC	$488M	$0 0.0% of portfolio	20	Q1 2025 Reduced 98.95%
RVPH Reviva Pharmaceuticals Holdings, Inc.	$9.2M	$0 0.0% of portfolio	200	Q2 2025 Reduced 99.91%
SRZNW Surrozen Inc Wt Exp 08/01/31 (	$0	$0 0.0% of portfolio	1,440	Q2 2025 Reduced 47.71%
VALN Valneva Se	$650M	$0 0.0% of portfolio	1	Q2 2025 Reduced 97.3%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.